Categories | Prevalence, n (%) N = 491 | No. Not Patient Prompted | USPSTF Recommendationsfor Screening |
---|---|---|---|
ENDOCRINE | |||
Adrenal adenoma | 2 (0.4) | 2 | NR |
Diabetes mellitus Type 2 | 3 (0.6) | 3 | B* |
Dyslipidemia | 40 (8.2) | 40 | A** |
Chronic fatigue | 1 (0.2) | 1 | NR |
Hyperparathyroidism | 6 (1.2) | 6 | NR |
Hyperthyroidism | 2 (0.4) | 2 | I |
Elevated lipoprotein (a) | 12 (2.4) | 12 | NR |
Metabolic syndrome | 6 (1.2) | 6 | NR |
Obesity | 95 (19.4) | 88 | B |
Class I | 72 | 67 | |
Class II | 13 | 12 | |
Class III | 10 | 9 | |
Osteoporosis | 9 (1.8) | 8 | B |
Thyroid nodule | 4 (0.8) | 2 | I |
Hashimoto’s thyroiditis | 1 (0.2) | 1 | I |
Thyrotoxicosis | 1 (0.2) | 1 | I |
Vertebral compression fracture | 2 (0.4) | 2 | NR |
TOTAL | 184 (37.4) | 174 | |
MALIGNANCY | |||
Non-melanoma skin | 8 (1.6) | 8 | I |
Melanoma | 7 (1.4) | 4 | I |
Prostate cancer | 4 (0.8) | 4 | D |
Renal cell carcinoma | 1 (0.2) | 1 | NR |
Pancreatic cancer | 1 (0.2) | 0 | D |
TOTAL | 21 (4.2) | 17 | |
PRE-MALIGNANT | |||
Colon polyp (large, multiple, tubulovillous+) | 5 (1.0) | 5 | A |
PSA elevation | 6 (1.2) | 6 | D |
Night sweats | 2 (0.4) | 0 | NR |
TOTAL | 13 (2.6) | 11 | |
CARDIOVASCULAR | |||
Aortic aneurysm, thoracic | 1 (0.2) | 1 | NR |
Aortic aneurysm, abdominal | 1 (0.2) | 1 | B |
Aortic dilatation (any area) | 2 (0.4) | 2 | NR |
Moderate aortic stenosis | 1 (0.2) | 1 | NR |
Aortic valve regurgitation | 2 (0.4) | 2 | NR |
Bicuspid aortic valve | 1 (0.2) | 1 | NR |
CAD, stable | 3 (0.6) | 3 | D |
CAD, unstable | 1 (0.2) | 0 | NR |
Chest pain | 4 (0.8) | 3 | NR |
LVH | 2 (0.4) | 2 | NR |
Patent foramen ovale | 1 (0.2) | 1 | NR |
Abnormal stress test | 2 (0.4) | 2 | D, I*** |
Congestive heart failure | 1 (0.2) | 0 | NR |
Peripheral artery disease | 1 (0.2) | 0 | D |
TOTAL | 23 (4.6) | 19 | |
GASTROENTEROLOGY | |||
Barrett’s esophagus | 1 (0.2) | 1 | NR |
Crohn’s disease | 1 (0.2) | 1 | NR |
Diverticulitis | 4 (0.8) | 3 | NR |
Diverticulosis | 1 (0.2) | 1 | NR |
Esophagitis | 6 (1.2) | 5 | NR |
Helicobacter pylori | 4 (0.8) | 3 | NR |
Hemochromatosis | 1 (0.2) | 1 | D |
Hepatitis C | 1 (0.2) | 1 | D |
Splenomegaly | 2 (0.4) | 2 | NR |
Steatohepatitis | 8 (1.6) | 8 | NR |
Mesenteric abscess | 1 (0.2) | 0 | NR |
Hematochezia | 2 (0.4) | 0 | NR |
TOTAL | 32 (6.4) | 25 | |
NEUROLOGY | |||
Cerebral infarction | 1 (0.2) | 0 | NR |
Lumbar stenosis | 1 (0.2) | 1 | NR |
Neuropathy | 6 (1.2) | 2 | NR |
Paresthesia | 12 (2.4) | 4 | NR |
Pituitary adenoma | 1 (0.2) | 1 | NR |
Seizure | 1 (0.2) | 1 | NR |
Syringomyelia | 1 (0.2) | 1 | NR |
Spinal syrinx | 1 (0.2) | 1 | NR |
Gliomatosis cerebri | 1 (0.2) | 0 | NR |
Transient ischemic attack | 1 (0.2) | 0 | NR |
TOTAL | 26 (5.2) | 11 | |
PULMONARY | |||
COPD | 3 (0.6) | 3 | D |
Obstructive sleep apnea | 24 (4.9) | 11 | NR |
Pleural effusion | 1 (0.2) | 1 | I |
Pleural thickening | 1 (0.2) | 1 | I |
Pneumonitis | 2 (0.4) | 2 | NR |
Upper airway resistance | 1 (0.2) | 1 | NR |
Asthma | 1 (0.2) | 0 | NR |
LTBI | 1 (0.2) | 1 | NR |
TOTAL | 34 (6.9) | 20 | |
NEPHROLOGY | |||
IGA nephropathy | 1 (0.2) | 1 | NR |
Medullary sponge kidney | 1 (0.2) | 1 | NR |
Nephrolithiasis | 3 (0.6) | 2 | NR |
Polycystic kidney disease | 2 (0.4) | 2 | NR |
Prerenal azotemia | 1 (0.2) | 1 | NR |
Renal insufficiency | 3 (0.6) | 3 | NR |
TOTAL | 11 (2.2) | 10 | |
OPHTHALMOLOGY | |||
Macular degeneration | 3 (0.6) | 3 | NR |
Glaucoma | 4 (0.8) | 4 | I |
Diabetic retinopathy | 1 (0.2) | 1 | NR |
TOTAL | 8 (1.6) | 8 | |
PSYCHIATRIC | |||
Depression | 9 (1.8) | 1 | B |
Eating disorder | 1 (0.2) | 1 | NR |
Adjustment disorder | 2 (0.4) | 0 | NR |
Anxiety | 8 (1.6) | 1 | NR |
TOTAL | 20 (4.0) | 3 | |
HEALTH HABITS | |||
Alcohol abuse | 5 (1.0) | 1 | B |
Nicotine dependency | 43 (8.8) | 2 | A |
TOTAL | 48 (9.8) | 3 | |
OTHER | |||
Hearing loss (severe/asymmetric) | 5 (1.0) | 3 | NR |
Seronegative spondyloarthropathy | 1 (0.2) | 0 | NR |
Infertility | 1 (0.2) | 0 | NR |
Otitis media | 1 (0.2) | 0 | NR |
TOTAL | 8 (1.6) | 3 | |
TOTAL | 428 (87.0) | 304 |